Specifically, in the tumor from patient #7, genes involved in T cell activation and signaling such as PTPRC (which encodes CD45), LCP2, FYB, CD3E, and LCK, and in genes involved in immune response and interferon signaling such as STAT1, OAS2, and HLA were downregulated. The gene discussed is OAS2; the disease is neoplasm.